Verve Therapeutics Cash Flow Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	-12.21	5.72	9.43	6.43	1.81
Depreciation & Amortization	13.1	12.42	9.74	3.93	3.34
Other Amortization	0.26	-	-	-	-
Loss (Gain) From Sale of Assets	-2.03	-0.22	-0.1	2.12	-0.11
Asset Writedown & Restructuring Costs	16.57	-	-	-	-
Other Operating Activities	8.76	2.45	-1.72	2.8	2.98
Change in Accounts Receivable	1.19	-	-	-	-
Change in Inventory	0.52	-	-	-	-
Change in Accounts Payable	0.07	-	-	-	-
Change in Unearned Revenue	-1.37	-	-	-	-
Change in Other Net Operating Assets	-2.66	9.58	6.19	3.44	7.26
Operating Cash Flow	22.21	29.96	23.54	18.73	15.29
Operating Cash Flow Growth	-25.86%	27.23%	25.69%	22.51%	-
Capital Expenditures	-4.15	-4.71	-5.5	-2.77	-2.87
Sale of Property, Plant & Equipment	0.06	1.47	0.24	0.06	1.72
Cash Acquisitions	-	-64.42	-57.55	-54.64	-8.78
Divestitures	1.02	-	-	-	-
Investment in Securities	-	-	0.01	-3.51	-0.01
Other Investing Activities	0	0.01	-	-0.22	0.03
Investing Cash Flow	-2.55	-66.91	-64.11	-61.35	-10.58
Long-Term Debt Issued	16.8	53.12	55.07	54.49	15.73
Long-Term Debt Repaid	-24.5	-27.09	-19.48	-17.13	-7.99
Net Debt Issued (Repaid)	-7.7	26.03	35.59	37.35	7.73
Issuance of Common Stock	0.35	17.67	9.71	14.64	-
Repurchase of Common Stock	-0.29	-3.05	-0.08	-0.29	-
Common Dividends Paid	-2.04	-2.06	-2.15	-	-2
Other Financing Activities	-9.85	-11.85	-4.48	-4.13	-2.68
Financing Cash Flow	-19.52	26.74	38.59	47.57	3.06
Foreign Exchange Rate Adjustments	0.05	-0.1	0.37	0.29	-0.15
Miscellaneous Cash Flow Adjustments	-	0	-	-0	0
Net Cash Flow	0.19	-10.31	-1.61	5.24	7.62
Free Cash Flow	18.06	25.25	18.04	15.96	12.42
Free Cash Flow Growth	-28.48%	39.92%	13.03%	28.51%	-
Free Cash Flow Margin	4.82%	6.91%	5.63%	9.02%	8.84%
Free Cash Flow Per Share	0.40	0.55	0.41	0.37	0.30
Cash Interest Paid	8.72	7.2	3.92	1.18	-
Cash Income Tax Paid	6.38	10.62	11.28	3.34	2.33
Levered Free Cash Flow	19.68	14.98	9.53	8.24	-
Unlevered Free Cash Flow	25.29	19.77	11.34	8.87	-
Change in Working Capital	-2.25	9.58	6.19	3.44	7.26

Source: S&P Global Market Intelligence. Standard template. Financial Sources.